Insider · CIK 0001949693
William Chou
ceopresidentofficerdirector
Files at PASG (Passage BIO, Inc.). First filing Jan 12, 2026, latest Jan 12, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $75k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PASG: Passage BIO, Inc.
PASGOct 9, 2026 · close 3.69
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Passage BIO, Inc. | $75k 4,076 shares | -38% | +248% from low-1% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | PASG Passage BIO, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +58,000 | $0.00 | $0 | 58,000 | Mar 18, 2026 |
| Jan 8, 2026 | PASG Passage BIO, Inc. | MOption exercise Common Stock | +10,000 | - | - | 10,600 | Jan 12, 2026 |
| Jan 8, 2026 | PASG Passage BIO, Inc. | SOpen-market sale Common Stock | -4,076 | $18.44 | $75k | 6,524 | Jan 12, 2026 |
| Jan 8, 2026 | PASG Passage BIO, Inc. | MOption exercise Restricted Stock Unitderivative | -10,000 | $0.00 | $0 | 10,000 | Jan 12, 2026 |
| Jan 15, 2025 | PASG Passage BIO, Inc. | AGrant or award Restricted Stock Unitderivative | +20,000 | $0.00 | $0 | 20,000 | Dec 29, 2025 |
| Mar 15, 2025 | PASG Passage BIO, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +779,533 | $0.00 | $0 | 779,533 | Mar 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.